Agenus (AGEN) to Release Earnings on Tuesday

Agenus (NASDAQ:AGEN) is projected to announce its earnings results before the market opens on Tuesday, March 11th. Analysts expect the company to announce earnings of ($2.36) per share and revenue of $30.09 million for the quarter. Investors that are interested in participating in the company’s conference call can do so using this link.

Agenus Price Performance

Shares of NASDAQ AGEN opened at $2.54 on Tuesday. The stock’s 50-day moving average is $3.30 and its two-hundred day moving average is $3.98. Agenus has a 1-year low of $2.50 and a 1-year high of $19.69. The company has a market cap of $59.59 million, a price-to-earnings ratio of -0.23 and a beta of 1.31.

Analysts Set New Price Targets

Separately, HC Wainwright restated a “neutral” rating on shares of Agenus in a report on Wednesday, January 22nd. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and a consensus price target of $10.00.

About Agenus

Agenus Inc, a clinical-stage biotechnology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies.